Skip to main content
Qiagen N.V. logo

Qiagen N.V. — Investor Relations & Filings

Ticker · QIA ISIN · NL0015001WM6 LEI · 54930036WK3GMCN17Z57 F Manufacturing
Open in API
Filings indexed 627 across all filing types
Latest filing 2002-06-28 Capital/Financing Update
Country NL Netherlands
Listing F QIA

About Qiagen N.V.

https://www.qiagen.com/

Qiagen N.V. is a global provider of "Sample to Insight" solutions, offering technologies that transform biological materials into valuable molecular insights. The company develops and markets sample and assay technologies, automated instrumentation, and bioinformatics software for molecular diagnostics, applied testing, academic research, and pharmaceutical development. Its comprehensive portfolio supports the entire workflow from sample collection and preparation of DNA, RNA, and proteins to analysis and interpretation. Key product areas include sample preparation kits, PCR, digital PCR (dPCR), and next-generation sequencing (NGS) solutions, as well as syndromic testing panels for infectious diseases.

Recent filings

Filing Released Lang Actions
FORM F-3
Capital/Financing Update Classification · 95% confidence The document is a Form F-3 Registration Statement filed with the SEC under the Securities Act of 1933. It is a registration statement for the sale of common shares by selling shareholders. The text includes detailed information about the offering, the company, legal disclaimers, incorporation by reference of other SEC filings (including annual reports on Form 20-F and quarterly reports on Form 6-K), and other regulatory disclosures. This type of document is a capital markets filing related to financing activities, specifically a securities registration for share sales. It is not an annual report, earnings release, or other financial report, but rather a capital/financing update regarding the registration and offering of shares. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial and contains detailed offering information, consistent with a CAP filing.
2002-06-28 English
AUTO-GENERATED PAPER DOCUMENT
Regulatory Filings
2002-06-25 English
FORM 6K
Interim / Quarterly Report Classification · 100% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, QIAGEN N.V., for the quarterly period ended March 31, 2002. It contains condensed consolidated financial statements including balance sheets, income statements, cash flows, notes to financial statements, segment information, and other financial data for the quarter. The document explicitly states it is prepared in accordance with US GAAP for interim financial information and references Form 10-Q instructions, indicating it is an interim/quarterly report. The length is substantial (15,000 characters) and contains actual financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2002-05-31 English
AUTO-GENERATED PAPER DOCUMENT
Regulatory Filings
2002-05-10 English
FORM 20-F
Annual Report
2002-04-02 English
AUTO-GENERATED PAPER DOCUMENT
Major Shareholding Notification
2002-02-14 English

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.